Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-20

Clinical Trial Update: Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Multi-Site Phase 2b Clinical Study [Phase 2]

View source ↗

Summary

Phase 2b randomized, double-blind trial for onychomycosis completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Onychomycosis | Phase 2 | Status: COMPLETED | Results posted: 2018-12-20